Edge
StocktwitsEarnings

Official STOCKTWITS Representative

$NBIX Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $1.43 up 31.19% YoY
• Reported revenue of $959M up 39.49% YoY
• Neurocrine Biosciences raised full year 2026 INGREZZA net product sales guidance to a range of $2.825 billion to $2.875 billion, up from the prior range of $2.7 billion to $2.8 billion.Price since post
Advertisement|Remove ads.